Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Epidemiology

Tea consumption and gastric cancer: a pooled analysis from the Stomach cancer Pooling (StoP) Project consortium

Abstract

Background

Evidence from epidemiological studies on the role of tea drinking in gastric cancer risk remains inconsistent. We aimed to investigate and quantify the relationship between tea consumption and gastric cancer in the Stomach cancer Pooling (StoP) Project consortium.

Methods

A total of 9438 cases and 20,451 controls from 22 studies worldwide were included. Odds ratios (ORs) and the corresponding 95% confidence intervals (CIs) of gastric cancer for regular versus non-regular tea drinkers were estimated by one and two-stage modelling analyses, including terms for sex, age and the main recognised risk factors for gastric cancer.

Results

Compared to non-regular drinkers, the estimated adjusted pooled OR for regular tea drinkers was 0.91 (95% CI: 0.85–0.97). When the amount of tea consumed was considered, the OR for consumption of 1–2 cups/day was 1.01 (95% CI: 0.94–1.09) and for >3 cups/day was 0.91 (95% CI: 0.80–1.03). Stronger inverse associations emerged among regular drinkers in China and Japan (OR: 0.67, 95% CI: 0.49–0.91) where green tea is consumed, in subjects with H. pylori infection (OR: 0.68, 95% CI: 0.58–0.80), and for gastric cardia cancer (OR: 0.64, 95% CI: 0.49–0.84).

Conclusion

Our results indicate a weak inverse association between tea consumption and gastric cancer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Overall regular tea consumption and gastric cancer.
Fig. 2: Categories of tea consumption and gastric cancer.
Fig. 3: Overall tea consumption and gastric cancer in strata of selected variables.
Fig. 4: Tea-drinking intensity (as a continuous variable) and gastric cancer.

Similar content being viewed by others

Data availability

Data supporting the results reported in the paper cannot be found on publicly available databases. Data can be provided on reasonable request from the authors.

References

  1. Statista. Volume of tea consumption worldwide from 2012 to 2025 (in million kilograms). 2021. https://www.statista.com/statistics/940102/global-tea-consumption/. Accessed 2 September 2021.

  2. Singh BN, Shankar S, Srivastava RK. Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol. 2011;82:1807–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Setiawan VW, Zhang ZF, Yu GP, Lu QY, Li YL, Lu ML, et al. Protective effect of green tea on the risks of chronic gastritis and stomach cancer. Int J Cancer. 2001;92:600–4.

    Article  CAS  PubMed  Google Scholar 

  4. Yu GP, Hsieh CC, Wang LY, Yu SZ, Li XL, Jin TH. Green-tea consumption and risk of stomach cancer: a population-based case-control study in Shanghai, China. Cancer Causes Control. 1995;6:532–8.

    Article  CAS  PubMed  Google Scholar 

  5. Deandrea S, Foschi R, Galeone C, La Vecchia C, Negri E, Hu J. Is temperature an effect modifier of the association between green tea intake and gastric cancer risk? Eur J Cancer Prev. 2010;19:18–22.

    Article  CAS  PubMed  Google Scholar 

  6. Kono S, Ikeda M, Tokudome S, Kuratsune M. A case-control study of gastric cancer and diet in northern Kyushu, Japan. Jpn J Cancer Res. 1988;79:1067–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Hoshiyama Y, Kawaguchi T, Miura Y, Mizoue T, Tokui N, Yatsuya H, et al. A nested case-control study of stomach cancer in relation to green tea consumption in Japan. Br J Cancer. 2004;90:135–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Hoshiyama Y, Sasaba T. A case-control study of single and multiple stomach cancers in Saitama Prefecture, Japan. Jpn J Cancer Res. 1992;83:937–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Galanis DJ, Kolonel LN, Lee J, Nomura A. Intakes of selected foods and beverages and the incidence of gastric cancer among the Japanese residents of Hawaii: a prospective study. Int J Epidemiol. 1998;27:173–80.

    Article  CAS  PubMed  Google Scholar 

  10. Nagano J, Kono S, Preston DL, Mabuchi K. A prospective study of green tea consumption and cancer incidence, Hiroshima and Nagasaki (Japan). Cancer Causes Control. 2001;12:501–8.

    Article  CAS  PubMed  Google Scholar 

  11. Tsubono Y, Nishino Y, Komatsu S, Hsieh CC, Kanemura S, Tsuji I, et al. Green tea and the risk of gastric cancer in Japan. N Engl J Med. 2001;344:632–6.

    Article  CAS  PubMed  Google Scholar 

  12. Fujino Y, Tamakoshi A, Ohno Y, Mizoue T, Tokui N, Yoshimura T. Prospective study of educational background and stomach cancer in Japan. Prev Med. 2002;35:121–7.

    Article  PubMed  Google Scholar 

  13. Hoshiyama Y, Kawaguchi T, Miura Y, Mizoue T, Tokui N, Yatsuya H, et al. A prospective study of stomach cancer death in relation to green tea consumption in Japan. Br J Cancer. 2002;87:309–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Sasazuki S, Inoue M, Hanaoka T, Yamamoto S, Sobue T, Tsugane S. Green tea consumption and subsequent risk of gastric cancer by subsite: the JPHC Study. Cancer Causes Control. 2004;15:483–91.

    Article  PubMed  Google Scholar 

  15. Khan MM, Goto R, Kobayashi K, Suzumura S, Nagata Y, Sonoda T, et al. Dietary habits and cancer mortality among middle aged and older Japanese living in hokkaido, Japan by cancer site and sex. Asian Pac J Cancer Prev. 2004;5:58–65.

    CAS  PubMed  Google Scholar 

  16. Kim TL, Jeong GH, Yang JW, Lee KH, Kronbichler A, van der Vliet HJ, et al. Tea consumption and risk of cancer: an umbrella review and meta-analysis of observational studies. Adv Nutr. 2020;11:1437–52.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Yu F, Jin Z, Jiang H, Xiang C, Tang J, Li T, et al. Tea consumption and the risk of five major cancers: a dose-response meta-analysis of prospective studies. BMC Cancer. 2014;14:197.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Zhao LG, Li ZY, Feng GS, Ji XW, Tan YT, Li HL, et al. Tea drinking and risk of cancer incidence: a meta-analysis of prospective cohort studies and evidence evaluation. Adv Nutr. 2021;12:402–12.

  19. Ren JS, Freedman ND, Kamangar F, Dawsey SM, Hollenbeck AR, Schatzkin A, et al. Tea, coffee, carbonated soft drinks and upper gastrointestinal tract cancer risk in a large United States prospective cohort study. Eur J Cancer. 2010;46:1873–81.

  20. Sanikini H, Dik VK, Siersema PD, Bhoo-Pathy N, Uiterwaal CS, Peeters PH, et al. Total, caffeinated and decaffeinated coffee and tea intake and gastric cancer risk: results from the EPIC cohort study. Int J Cancer. 2015;136:E720–30.

    Article  CAS  PubMed  Google Scholar 

  21. World Cancer Research Fund/American Institute for Research. Continuous Update Project Expert Report 2018. Non-alcoholic drinks and the risk of cancer. 2018. https://www.wcrf.org/wp-content/uploads/2021/02/Non-alcoholic-drinks.pdf. Accessed 2 September 2021.

  22. Pelucchi C, Lunet N, Boccia S, Zhang ZF, Praud D, Boffetta P, et al. The stomach cancer pooling (StoP) project: study design and presentation. Eur J Cancer Prev. 2015;24:16–23.

    Article  PubMed  Google Scholar 

  23. Benetou V, Trichopoulou A, Orfanos P, Naska A, Lagiou P, Boffetta P, et al. Conformity to traditional Mediterranean diet and cancer incidence: the Greek EPIC cohort. Br J Cancer. 2008;99:191–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Lagiou P, Samoli E, Lagiou A, Peterson J, Tzonou A, Dwyer J, et al. Flavonoids, vitamin C and adenocarcinoma of the stomach. Cancer Causes Control 2004;15:67–72.

    Article  CAS  PubMed  Google Scholar 

  25. Buiatti E, Palli D, Decarli A, Amadori D, Avellini C, Bianchi S, et al. A case-control study of gastric cancer and diet in Italy. Int J Cancer. 1989;44:611–6.

    Article  CAS  PubMed  Google Scholar 

  26. La Vecchia C, D’Avanzo B, Negri E, Decarli A, Benichou J. Attributable risks for stomach cancer in northern Italy. Int J Cancer. 1995;60:748–52.

    Article  PubMed  Google Scholar 

  27. Lucenteforte E, Scita V, Bosetti C, Bertuccio P, Negri E, La Vecchia C. Food groups and alcoholic beverages and the risk of stomach cancer: a case-control study in Italy. Nutr Cancer. 2008;60:577–84.

    Article  PubMed  Google Scholar 

  28. Mao Y, Hu J, Semenciw R, White K. Active and passive smoking and the risk of stomach cancer, by subsite, in Canada. Eur J Cancer Prev. 2002;11:27–38.

    Article  CAS  PubMed  Google Scholar 

  29. Zaridze D, Borisova E, Maximovitch D, Chkhikvadze V. Alcohol consumption, smoking and risk of gastric cancer: case-control study from Moscow, Russia. Cancer Causes Control 2000;11:363–71.

    Article  CAS  PubMed  Google Scholar 

  30. Lunet N, Valbuena C, Vieira AL, Lopes C, Lopes C, David L, et al. Fruit and vegetable consumption and gastric cancer by location and histological type: case-control and meta-analysis. Eur J Cancer Prev. 2007;16:312–27.

    Article  PubMed  Google Scholar 

  31. Schatzkin A, Subar AF, Thompson FE, Harlan LC, Tangrea J, Hollenbeck AR, et al. Design and serendipity in establishing a large cohort with wide dietary intake distributions: the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol. 2001;154:1119–25.

    Article  CAS  PubMed  Google Scholar 

  32. Zhang ZF, Kurtz RC, Klimstra DS, Yu GP, Sun M, Harlap S, et al. Helicobacter pylori infection on the risk of stomach cancer and chronic atrophic gastritis. Cancer Detection Prev. 1999;23:357–67.

    Article  CAS  Google Scholar 

  33. Ward MH, Sinha R, Heineman EF, Rothman N, Markin R, Weisenburger DD, et al. Risk of adenocarcinoma of the stomach and esophagus with meat cooking method and doneness preference. Int J Cancer. 1997;71:14–9.

    Article  CAS  PubMed  Google Scholar 

  34. Santibañez M, Alguacil J, de la Hera MG, Navarrete-Muñoz EM, Llorca J, Aragonés N, et al. Occupational exposures and risk of stomach cancer by histological type. Occup Environ Med. 2012;69:268–75.

    Article  PubMed  Google Scholar 

  35. Machida-Montani A, Sasazuki S, Inoue M, Natsukawa S, Shaura K, Koizumi Y, et al. Association of Helicobacter pylori infection and environmental factors in non-cardia gastric cancer in Japan. Gastric Cancer. 2004;7:46–53.

    Article  PubMed  Google Scholar 

  36. Hernández-Ramírez RU, Galván-Portillo MV, Ward MH, Agudo A, González CA, Oñate-Ocaña LF, et al. Dietary intake of polyphenols, nitrate and nitrite and gastric cancer risk in Mexico City. Int J Cancer. 2009;125:1424–30.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  37. Hamada GS, Kowalski LP, Nishimoto IN, Rodrigues JJ, Iriya K, Sasazuki S, et al. Risk factors for stomach cancer in Brazil (II): a case-control study among Japanese Brazilians in São Paulo. Jpn J Clin Oncol. 2002;32:284–90.

    Article  PubMed  Google Scholar 

  38. Nishimoto IN, Hamada GS, Kowalski LP, Rodrigues JG, Iriya K, Sasazuki S, et al. Risk factors for stomach cancer in Brazil (I): a case-control study among non-Japanese Brazilians in São Paulo. Jpn J Clin Oncol. 2002;32:277–83.

    Article  PubMed  Google Scholar 

  39. Bartelli TF, Senda de Abrantes LL, Freitas HC, Thomas AM, Silva JM, Albuquerque GE, et al. Genomics and epidemiology for gastric adenocarcinomas (GE4GAC): a Brazilian initiative to study gastric cancer. Appl Cancer Res. 2019;39:12.

    Article  Google Scholar 

  40. Pourfarzi F, Whelan A, Kaldor J, Malekzadeh R. The role of diet and other environmental factors in the causation of gastric cancer in Iran-a population based study. Int J Cancer. 2009;125:1953–60.

    Article  CAS  PubMed  Google Scholar 

  41. Mu LN, Lu QY, Yu SZ, Jiang QW, Cao W, You NC, et al. Green tea drinking and multigenetic index on the risk of stomach cancer in a Chinese population. Int J Cancer. 2005;116:972–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Setiawan VW, Yu GP, Lu QY, Lu ML, Yu SZ, Mu L, et al. Allium vegetables and stomach cancer risk in China. Asian Pac J Cancer Prev. 2005;6:387–95.

    PubMed  Google Scholar 

  43. Setiawan VW, Zhang ZF, Yu GP, Li YL, Lu ML, Tsai CJ, et al. GSTT1 and GSTM1 null genotypes and the risk of gastric cancer: a case-control study in a Chinese population. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive. Oncology. 2000;9:73–80.

    CAS  Google Scholar 

  44. Boccia S, Sayed-Tabatabaei FA, Persiani R, Gianfagna F, Rausei S, Arzani D, et al. Polymorphisms in metabolic genes, their combination and interaction with tobacco smoke and alcohol consumption and risk of gastric cancer: a case-control study in an Italian population. BMC Cancer. 2007;7:206-.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  45. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.

    Article  CAS  PubMed  Google Scholar 

  46. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.

    Article  PubMed  Google Scholar 

  47. Desquilbet L, Mariotti F. Dose-response analyses using restricted cubic spline functions in public health research. Stat Med. 2010;29:1037–57.

    PubMed  Google Scholar 

  48. Tong GX, Liang H, Chai J, Cheng J, Feng R, Chen PL, et al. Association of risk of gastric cancer and consumption of tobacco, alcohol and tea in the Chinese population. Asian Pac J Cancer Prev. 2014;15:8765–74.

    Article  PubMed  Google Scholar 

  49. Lin Y, Wu C, Yan W, Guo S, Lin S, Liu B. Sociodemographic and lifestyle factors in relation to gastric cancer in a high-risk region of China: a matched case-control study. Nutr Cancer. 2020;72:421–30.

    Article  PubMed  Google Scholar 

  50. Poorolajal J, Moradi L, Mohammadi Y, Cheraghi Z, Gohari-Ensaf F. Risk factors for stomach cancer: a systematic review and meta-analysis. Epidemiol Health. 2020;42:e2020004.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Jeong M, Park JM, Han YM, Kangwan N, Kwon SO, Kim BN, et al. Dietary intervention of artemisia and green tea extracts to rejuvenate helicobacter pylori-associated chronic atrophic gastritis and to prevent tumorigenesis. Helicobacter. 2016;21:40–59.

    Article  CAS  PubMed  Google Scholar 

  52. Stoicov C, Saffari R, Houghton J. Green tea inhibits Helicobacter growth in vivo and in vitro. Int J Antimicrob Agents. 2009;33:473–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Boyanova L, Ilieva J, Gergova G, Vladimirov B, Nikolov R, Mitov I. Honey and green/black tea consumption may reduce the risk of Helicobacter pylori infection. Diagn Microbiol Infect Dis. 2015;82:85–6.

    Article  CAS  PubMed  Google Scholar 

  54. Mao XQ, Jia XF, Zhou G, Li L, Niu H, Li FL, et al. Green tea drinking habits and gastric cancer in southwest China. Asian Pac J Cancer Prev. 2011;12:2179–82.

    PubMed  Google Scholar 

  55. Huang Y, Chen H, Zhou L, Li G, Yi D, Zhang Y, et al. Association between green tea intake and risk of gastric cancer: a systematic review and dose-response meta-analysis of observational studies. Public Health Nutr. 2017;20:3183–92.

    Article  PubMed  Google Scholar 

  56. Wang Y, Duan H, Yang H. A case-control study of stomach cancer in relation to Camellia sinensis in China. Surg Oncol. 2015;24:67–70.

    Article  CAS  PubMed  Google Scholar 

  57. Morais S, Peleteiro B, Araújo N, Malekzadeh R, Ye W, Plymoth A, et al. Identifying the profile of Helicobacter pylori-negative gastric cancers: a case-only analysis within the Stomach Cancer Pooling (StoP) Project. Cancer Epidemiol Biomark Prev. 2022;31:200–9.

    Article  Google Scholar 

Download references

Acknowledgements

We thank the European Cancer Prevention (ECP) Organization for providing support for the StoP meetings.

Funding

This study was supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC), Project no. 21378 (Investigator Grant) and by the Italian League for the Fight Against Cancer (LILT). Brazilian data collection received support from Fundação de Amparo à Pesquisa do Estado de São Paulo (14/26897-0). NL and SM are funded under the Unidade de Investigação em Epidemiologia—Instituto de Saúde Pública da Universidade do Porto (EPIUnit; UIDB/04750/2020) financed by national funds from the Foundation for Science and Technology—FCT (Portuguese Ministry of Science, Technology and Higher Education). SM also received funding under the scope of the project ‘NEON-PC—Neuro-oncological complications of prostate cancer: longitudinal study of cognitive decline’ (POCI-01-0145-FEDER-032358; Ref. PTDC/SAU-EPI/32358/2017) funded by FEDER through the Operational Program Competitiveness and Internationalization, and national funding from FCT, and the EPIUnit—Junior Research—Prog Financing (UIDP/04750/2020).

Author information

Authors and Affiliations

Authors

Contributions

Study concept and design: GM, CP, CL and EN. Acquisition, processing and reporting of samples: RB, JH, KCJ, CSR, LML, RS, ZFZ, MD, NL, SM, DP, MF, GPY, ST, AH, MPC, EDN, DZ, DM, JV, MGH, LLC, RUHR, GSH, MHW, LM, RM, FP, AT, AK, RCK, AL, PL, SB, PB and MCC. Analysis and interpretation of the data: GM, CP, GA, MR and CL. Drafting of the manuscript: GM, CP, GA and CL. Critical revision of the manuscript: all authors.

Corresponding author

Correspondence to Georgia Martimianaki.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval and consent to participate

The participating studies were performed in accordance with laws, regulations and guidelines for the protection of human subjects (including consent from the participants) applicable at the time of study conduction, and in accordance with the Declaration of Helsinki. All identifying information was removed before data were pooled at the study coordinating centre located at the University of Milan. The StoP Project received ethical approval from the University of Milan Review Board (reference 19/15 on 01/04/2015).

Consent for publication

Not applicable

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Martimianaki, G., Alicandro, G., Pelucchi, C. et al. Tea consumption and gastric cancer: a pooled analysis from the Stomach cancer Pooling (StoP) Project consortium. Br J Cancer 127, 726–734 (2022). https://doi.org/10.1038/s41416-022-01856-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41416-022-01856-w

This article is cited by

Search

Quick links